AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2012

Sep 20, 2012

32870_dirs_2012-09-20_c0cca131-9e27-4405-bd43-f81c4e99db87.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2012-09-18

Reporting Person: Intervac, L.L.C. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-18	Common Stock	J	150000	—	Disposed	4344250	Direct

Footnotes

F1: The disposition reported on this line occurred as a result of a partial redemption of Intervac, L.L.C. membership interests. There was no sale of securities by Intervac, L.L.C.